Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
IndustryARC
industryarc.com/
Venkat Reddy
venkat@industryarc.com
(+1) 614-588-8538

Bookmark and Share
IVIG Market Will Benefit from Increase in Geriatric Population and Hemophilic Patients
During the forecast period of 2019-2025, the IVIG market will grow with a CAGR of 7.2%.


IVIG Market
BriefingWire.com, 10/09/2019 - According to the Immune Deficiency Foundation, approximately 350 rare, primary immunodeficiency diseases have been diagnosed in the world. These diseases lead to deterioration or dysfunction of the immunity system, thus generating a necessity for external immunoglobulins. Autoimmune diseases can affect people of any age and gender and are quite often present since infancy. This renders doctors with intravenous immunoglobulin as the best possible solution to alleviate the symptoms, especially in children. Furthermore, shifting preference towards IVIG over steroids has been observed in the healthcare industry.

Reducing symptoms or curing the disease through steroids is an expensive procedure and can have side effects as well. However, the IVIG market has benefitted tremendously from this factor and earned a revenue of $9.6 billion in 2018. During the forecast period of 2019-2025, the IVIG Market will grow with a CAGR of 7.2%.

Prevalent Incidence of Hemophilia Will Positively Impact The Global IVIG Market

With the entire world population taken into consideration, hemophilia appears to be a rare medical condition. However, hemophilia is a serious autoimmune condition occurring predominantly in males causing internal bleeding in different parts of the body. According to statistics by the Centers for Disease Control and Prevention, the A type of this condition affects 1 in every 5000 male births, and approximately 400 babies are born with Hemophilia A every year in the U.S. Recent findings have also suggested that family history is crucial in the incidence of hemophilia. An individual is more likely to suffer from this condition if a family member has suffered from the same. This condition is detrimental to joints and mobility in individuals and gets worse with aging.

Browse IVIG Market Report Link:

www.industryarc.com/Report/15925/ivig-market.html

The Aging of Immunity System Will Provide Impetus to the Global IVIG Market

Statistics from eminent organizations across the world are pointing towards the visible rise in the geriatric population. According to the United States Census Bureau, by the year 2030, the number of older people in the U.S. will become more than the number of children. This increase will occur owing to the improvement of healthcare facilities, falling birth rates in most countries, and rapid migration to first world countries. The geriatric population is highly prone to a consistent weakening of the immunity system.

Key Players of the IVIG Market

The global IVIG market revenue growth can be attributed to distribution and production strategies of key market players. Since immunoglobulin is mainly acquired from blood donations, market players have been pivotal in generating awareness for increasing voluntary blood donations. The main companies of the IVIG market include Biotest AG, Baxter International Inc., Octapharma AG, LFB Biotechnologies, Grifols SA, CSL Behring, China Biologics Products Inc., Kedrion Biopharma, and BDI Pharma Inc.

To request for a proposal, provide your details in the below link:

www.industryarc.com/reports/request-quote?id=15925

About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2019 Proserve Technology, Inc.